This study employed simultaneous neuroimaging with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to demonstrate the relationship between changes in receptor occupancy measured by PET and changes in brain activity inferred by fMRI. By administering the D2/D3 dopamine receptor antagonist [11C]raclopride at varying specific activities to anesthetized nonhuman primates, we mapped associations between changes in receptor occupancy and hemodynamics [cerebral blood volume (CBV)] in the domains of space, time, and dose. Mass doses of raclopride above tracer levels caused increases in CBV and reductions in binding potential that were localized to the dopamine-rich striatum. Moreover, similar temporal profiles we...
For >30 years, positron emission tomography (PET) has proven to be a powerful approach for measur...
Positron Emission Tomography (PET) imaging allows the estimation of multiple aspects of dopamine fun...
The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson's disease has ...
This report describes a multi-receptor physiological model of the fMRI temporal response and signal ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Electrical Engineering and Comp...
The dopamine D2/3 system is fundamental for sensory, motor, emotional, and cognitive aspects of beha...
The dopamine (DA) system in brain has attracted considerable attention in neuroscience due to its in...
Functional neurochemical imaging can indicate neurotransmitter release by detecting changes in recep...
Functional neurochemical imaging can indicate neurotransmitter release by detecting changes in recep...
The modulatory neurotransmitter dopamine (DA) is involved in movement and reward behaviors, and malf...
Positron emission tomography (PET) has been widely used to study non-invasively function of the brai...
The metabolic activation resulting from direct dopaminergic stimulation can be detected using auto-r...
Competition by endogenous dopamine with the binding of D2 dopamine receptor ligands may be important...
Anesthesia and restraint stress have profound impacts on brain functions, including neural activity ...
Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal chang...
For >30 years, positron emission tomography (PET) has proven to be a powerful approach for measur...
Positron Emission Tomography (PET) imaging allows the estimation of multiple aspects of dopamine fun...
The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson's disease has ...
This report describes a multi-receptor physiological model of the fMRI temporal response and signal ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Electrical Engineering and Comp...
The dopamine D2/3 system is fundamental for sensory, motor, emotional, and cognitive aspects of beha...
The dopamine (DA) system in brain has attracted considerable attention in neuroscience due to its in...
Functional neurochemical imaging can indicate neurotransmitter release by detecting changes in recep...
Functional neurochemical imaging can indicate neurotransmitter release by detecting changes in recep...
The modulatory neurotransmitter dopamine (DA) is involved in movement and reward behaviors, and malf...
Positron emission tomography (PET) has been widely used to study non-invasively function of the brai...
The metabolic activation resulting from direct dopaminergic stimulation can be detected using auto-r...
Competition by endogenous dopamine with the binding of D2 dopamine receptor ligands may be important...
Anesthesia and restraint stress have profound impacts on brain functions, including neural activity ...
Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal chang...
For >30 years, positron emission tomography (PET) has proven to be a powerful approach for measur...
Positron Emission Tomography (PET) imaging allows the estimation of multiple aspects of dopamine fun...
The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson's disease has ...